Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
25.37
-1.17 (-4.41%)
May 14, 2025, 9:30 AM - Market open
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $237.35 million as of May 14, 2025. Its market cap has increased by 534.63% in one year.
Market Cap
237.35M
Enterprise Value
n/a
1-Year Change
534.63%
Ranking
Category
Stock Price
$25.37
Market Cap Chart
Since January 31, 2014, Tvardi Therapeutics's market cap has decreased from $282.00M to $237.35M, a decrease of -15.83%. That is a compound annual growth rate of -1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 121.40M | 333.57% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |